STOCK TITAN

Capricor (NASDAQ: CAPR) EVP exercises options and sells 24,100 shares under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CAPRICOR THERAPEUTICS, INC. EVP and General Counsel Karen Krasney exercised stock options to acquire 24,100 shares of common stock at $3.18 per share and sold 24,100 shares in open-market transactions at a weighted average price of $30.38 per share. The sales were made under a pre-arranged Rule 10b5-1 trading plan and occurred in multiple trades between $30.00 and $30.88. Following these transactions, she holds 30,547 shares of common stock and 31,261 stock options directly.

Positive

  • None.

Negative

  • None.
Insider Krasney Karen
Role EVP, GENERAL COUNSEL
Sold 24,100 shs ($732K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 24,100 $0.00 --
Exercise Common Stock 24,100 $3.18 $77K
Sale Common Stock 24,100 $30.38 $732K
Holdings After Transaction: Stock Option (Right to Buy) — 31,261 shares (Direct, null); Common Stock — 54,647 shares (Direct, null)
Footnotes (1)
  1. Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.88, inclusive. Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Shares sold 24,100 shares Common stock sold in open-market transactions
Weighted average sale price $30.38 per share Open-market sales on June 25, 2026
Option exercise price $3.18 per share Stock options exercised for 24,100 shares
Shares held after 30,547 shares Direct common stock holdings following transactions
Options remaining 31,261 options Stock options outstanding after partial exercise
Sale price range $30.00–$30.88 Price range of individual sale trades
Net share change (buy/sell) -24,100 shares Net effect of sales versus purchases
Rule 10b5-1 trading plan regulatory
"Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) listed as a derivative security with underlying common stock shares..."
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security for the option exercise entries..."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vesting financial
"Shares vested 1/48th on the first day of each month commencing February 1, 2022."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Krasney Karen

(Last)(First)(Middle)
C/O CAPRICOR THERAPEUTICS, INC.
10865 ROAD TO THE CURE, SUITE 150

(Street)
SAN DIEGO CALIFORNIA 92121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CAPRICOR THERAPEUTICS, INC. [ CAPR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, GENERAL COUNSEL
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/25/2026M24,100A$3.1854,647D
Common Stock06/25/2026S(1)24,100D$30.38(2)30,547D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$3.1806/25/2026M24,100 (3)01/03/2032Common Stock24,100$031,261D
Explanation of Responses:
1. Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
2. The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.88, inclusive.
3. Shares vested 1/48th on the first day of each month commencing February 1, 2022.
/s/ Linda Marban, Attorney-in-Fact06/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CAPR executive Karen Krasney report on this Form 4?

Karen Krasney reported exercising options and selling shares of CAPR stock. She exercised 24,100 stock options at $3.18 each, then sold 24,100 common shares in open-market trades at a weighted average price of $30.38 per share on the same date.

How many CAPR shares did Karen Krasney sell and at what prices?

She sold 24,100 CAPR common shares in open-market transactions. The weighted average sale price was $30.38 per share, with individual trades executed in a price range from $30.00 to $30.88, as disclosed in the Form 4 footnotes.

Were Karen Krasney’s CAPR stock sales under a Rule 10b5-1 trading plan?

Yes. The Form 4 states the shares were sold pursuant to a Rule 10b5-1 trading plan adopted in December 2025. Such pre-arranged plans automate trading, indicating the timing of these sales was set in advance rather than chosen at the moment.

How many CAPR shares does Karen Krasney hold after these transactions?

After the reported transactions, she directly holds 30,547 shares of CAPRICOR THERAPEUTICS common stock. In addition, she has 31,261 stock options outstanding, providing the right to buy further shares before their stated expiration date in 2032.

What stock options did Karen Krasney exercise in the CAPR Form 4 filing?

She exercised 24,100 stock options with a conversion or exercise price of $3.18 per share, receiving the same number of common shares. The options are described as “Stock Option (Right to Buy)” and were scheduled to vest monthly beginning February 1, 2022.

What does the CAPR Form 4 reveal about remaining options for Karen Krasney?

Following the option exercise, 31,261 stock options remain outstanding for Karen Krasney. These options carry an exercise price of $3.18 per share and have an expiration date in January 2032, according to the derivative transaction data disclosed.